CD40 and CD40L interact to mediate anti-tumor immune responses by increasing immunogenic cell death (ICD) of tumor cells, activating antigen-presenting cells, producing proinflammatory factors and stimulating CD4+ and CD8+ T cells [181]. Here, CD4 is linked to neoplasm.